Report on Global and Chinese IVD Industry_Proposal

1. INTRODUCTION
Two thirds of medical treatment decisions in the global was made based on assay results, however, spending on assays only makes up 1% of total medical expenditures. To improve the technology, methods and spending on assays would contribute to disease prevention, diagnosis and treatment. It demonstrates commercial opportunities as well.
The major market demand of IVD comes from developed countries such as North America, Europe, Japan, etc., nonetheless, developing countries such as China, India and Brazil has shown increasing demand in recent years. So far, there are around 400 IVD companies in China, with the top 20 occupying 30% of the market share. The market size of IVD in China was about RMB15 billion in 2013, which will grow to RMB30 million in 2018.
In this report, ASKCI analyzes IVD in China to provide understanding of this industry in terms of market demand, key players, regulations, etc. Meanwhile, recommendations will be given at the end of the report to describe the prospect and provide forward-thinking strategies.

Part Contents
Executive Summary
Definition and Methodology
I Overview of IVD in the Globe
I-1 General Introduction
I-2 Market Size
I-3 Market Segment
II Overview of IVD in China
II-1 General Introduction
II-2 Market Size
II-3 Market Segment
II-4 Industrial Chain
II-5 Regulation and Policy
III Analysis of Global IVD by Market Segment
III-1 Point-of-care Tests
III-2 Core Laboratory Tests
III-3 Molecular Assays
III-4 Hematology
III-5 Coagulation
III-6 Microbiology
III-7 Tests Used in Blood Banking
III-8 Histology and Cytology
IV Analysis of Chinese IVD by Market Segment
IV-1 Molecular Assays
IV-1.1 Overview
IV-1.2 Market Size
IV-1.3 Application
IV-2 Immunoassays
IV-3 Biochemical Assays
IV-4 Blood and Humoral Assays
IV-5 Microbiological Assays
V Key Players of IVD in the Globe
V-1 Abbott Laboratories
V-2 Becton, Dickinson & Co.
V-3 Danaher Corp.
V-4 Johnson & Johnson
V-5 Roche
V-6 Siemens
VI Key Players of IVD in China
VI-1 Key Players for Molecular Assays
VI-1.1 Daan Gene
VI-1.1.1 Company Introduction
VI-1.1.2 Product Category
VI-1.1.3 Operation Analysis
VI-1.2 Kehua Bio-engineering
VI-1.3 ZJ Bio-Tech
VI-1.4 Fosun Pharma
VI-2 Key Players for Immunoassays
VI-2.1 Wantai BioPharm
VI-2.2 InTec
VI-2.3 Rongsheng Biotech
VI-3 Key Players for Clinical Biochemical Assays
VI-3.1 Leadman
VI-3.2 Beijing Strong Biotechnologies
VII Prospect of IVD in China
VIII Conclusion and Recommendations
ASKCI's Legal Disclaimer